Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 3/20 | 0.46 |
| ▸ | CCR5 | P51681 | 7/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | HTR7 | P34969 | 1/20 | 0.44 |
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26434787 | 0.90 | MRGPRX4 (0.58) | MRGPRX4NPC1RAB9AMAPTALDH1A1 | |
| SCHEMBL15588794 | 0.87 | MRGPRX4 (0.56) | MRGPRX4NPC1RAB9AMAPTALDH1A1 | |
| SCHEMBL5275479 | 0.83 | SMN1; SMN2 (0.49) | NPC1RAB9AMAPTALDH1A1CYP1A2 | |
| SCHEMBL171841 | 0.83 | MRGPRX4 (0.68) | MRGPRX4MAPTMAOBSMN1; SMN2HTT | |
| SCHEMBL16210326 | 0.81 | CCR5 (0.45) | NPC1RAB9AMAPTALDH1A1LMNA | |
| SCHEMBL257777 | 0.81 | MRGPRX4 (0.57) | MRGPRX4LMNAHTT | |
| SCHEMBL19374625 | 0.80 | MRGPRX4 (0.50) | MRGPRX4RAB9AMAPTALDH1A1RECQL | |
| SCHEMBL16210297 | 0.80 | MRGPRX4 (0.53) | MRGPRX4NPC1RAB9AMAPTALDH1A1 | |
| SCHEMBL26698908 | 0.80 | MRGPRX4 (0.56) | MRGPRX4NPC1RAB9AMAPTLMNA | |
| SCHEMBL29227167 | 0.77 | LMNA (0.58) | NPC1RAB9AMAPTALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9079836-B2 | Compound having 2-fluorophenyloxymethane structure, a method for preparing the same, a liquid crystal composition and a liquid crystal device | DIC CORPORATION (JP) | 2015-07-14 | — | — | US | disclosed |
| US-9079836-B2 | Compound having 2-fluorophenyloxymethane structure, a method for preparing the same, a liquid crystal composition and a liquid crystal device | DIC CORPORATION (JP) | 2015-07-14 | — | — | US | disclosed |
| US-9079836-B2 | Compound having 2-fluorophenyloxymethane structure, a method for preparing the same, a liquid crystal composition and a liquid crystal device | DIC CORPORATION (JP) | 2015-07-14 | — | — | US | disclosed |
| US-20140330045-A1 | COMPOUND HAVING 2-FLUOROPHENYLOXYMETHANE STRUCTURE | DIC CORPORATION (JP) | 2014-11-06 | — | — | US | disclosed |
| US-20140330045-A1 | COMPOUND HAVING 2-FLUOROPHENYLOXYMETHANE STRUCTURE | DIC CORPORATION (JP) | 2014-11-06 | — | — | US | disclosed |
| US-20140330045-A1 | COMPOUND HAVING 2-FLUOROPHENYLOXYMETHANE STRUCTURE | DIC CORPORATION (JP) | 2014-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140330045-A1 | COMPOUND HAVING 2-FLUOROPHENYLOXYMETHANE STRUCTURE | INF2, CFL1, CFD | MRGPRX4 2277/4885NPC1 1856/4885RAB9A 899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.